Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Per Hartvig Honoré"'
Publikováno v:
Basic & Clinical Pharmacology & Toxicology. 121:325-333
The purpose of the study was to investigate the clinical effect of a clinical pharmacist (CP) intervention upon admission to hospital on inpatient harm and to assess a potential educational bias. Over 16 months, 593 adult patients taking ≥4 medicat
Publikováno v:
European Journal of Hospital Pharmacy. 21:8-12
The use of fixed-dose combinations (FDCs) in the daily practice of pharmacotherapy is increasing after years in the shadows. The main reasons for this renewed popularity are the increasing number of drugs prescribed per patient and the complexity of
Publikováno v:
Journal of Oncology Pharmacy Practice. 20:270-277
Objectives To highlight the health-related quality of life scale scores for Saudi patients with different types of cancer, to get understanding and foundation for improvements. To suggest suitable plans for quality of life improvement based on study
Publikováno v:
Rune Högh Nielsen, T, Ejdrup Andersen, S, Rasmusen, M & Honoré, P G H 2013, ' Clinical pharmacy services in the acute ward ', International Journal of Clinical Pharmacy, vol. 35, no. 6, pp. 1137-41 . https://doi.org/10.1007/s11096-013-9837-1
Background The majority of hospitalised patients have drug-related problems. Clinical pharmacist services including medication history, medication reconciliation and medication review may reduce the number of drug-related problems. Acute and emergenc
Autor:
Mette Rasmussen, Stig Andersen, Per Hartvig Honoré, Trine Rune Høgh Nielsen, Majbritt Grabas Kruse
Publikováno v:
European Journal of Hospital Pharmacy. 20:297-301
Objectives Patients’ own drugs (PODs) are the medicines that patients have obtained in the community setting and bring to hospital. Little is known about the frequency with which patients bring PODs when admitted to hospital and the quality of thes
Autor:
Ove Juul Nielsen, Morten K. Jensen, Hannah Søndergaard Jensen, Mikkel Krogh-Madsen, Per Hartvig Honoré, Steen Hansen Honoré
Publikováno v:
European Journal of Hospital Pharmacy. 20:185-188
Objective To investigate the uracil arabinoside/cytarabine (Ara-U/Ara-C) ratios with the lower dose in adult acute myeloid leukaemia (AML) induction therapy (100 mg/m 2 Ara-C) where no enzyme saturation is expected. Methods A precise and robust high-
Autor:
Morten K. Jensen, Per Hartvig Honoré, Lena E. Friberg, Mikkel Krogh-Madsen, Brendan C. Bender, Ove Juul Nielsen
Publikováno v:
Cancer Chemotherapy and Pharmacology. 69:1155-1163
Interpatient variability in the pharmacokinetics (PK) of cytarabine, etoposide, and daunorubicin following body surface area-adjusted doses calls for studies that point to other covariates to explain this variability. The purpose of this study was to
Autor:
Pia Møllgaard, Per Hartvig Honoré, Signe Neustrup, Pernille Kristensen, Anna Basnet, Ole J. Bjerrum, Laila Eljaja, Lene Munkholm Andersen
Publikováno v:
Scandinavian Journal of Pain. 2:178-184
Introduction The pathophysiologic and neurochemical characteristics of neuropathic pain must be considered in the search for new treatment targets. Breakthroughs in the understanding of the structural and biochemical changes in neuropathy have opened
Autor:
Lene Munkholm Andersen, Anna Basnet, Ole J. Bjerrum, Pernille Kristensen, Laila Eljaja, Per Hartvig Honoré, Signe Neustrup, Pia Møllgaard
Publikováno v:
Scandinavian Journal of Pain. 2:172-177
Introduction Animal disease models are predictive for signs seen in disease. They may rarely mimic all signs in a specific disease in humans with respect to etiology, cause or development. Several models have been developed for different pain states
Publikováno v:
Scandinavian Journal of Pain. 2:132-136
Glutamate is the major excitatory amino acid in the mammalian CNS and is involved in transmission of pain together with processes for cognition, memory and learning. In order to terminate glutamatergic neurotransmission and avoid excitotoxic damage,